期刊的影响因子--文章列表

期刊文章列表
Yaosheng Li¹，Honghui Wu¹，Xinchi Jiang^1,2，Yunfei Dong¹，Juanjuan Zheng¹，Jianqing Gao^1,2,3（Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University；Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University；Hangzhou Institute of Innovative Medicine,Zhejiang University）.New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders：Combining with intranasal delivery[J].Acta Pharmaceutica Sinica B,2022,第8期 Longlong Zhang^1,2，Yuefei Zhu¹，Xunbin Wei³，Xing Chen^1,2，Yang Li^1,2，Ying Zhu¹，Jiaxuan Xia¹，Yiheng Huang¹，Yongzhuo Huang⁴，Jianxin Wang^1,2,5，Zhiqing Pang^1,2（Department of Pharmaceutics,School of Pharmacy,Fudan University；Key Laboratory of Smart Drug Delivery,Ministry of Education；State Key Laboratory of Oncogenes and Related Genes,Shanghai Cancer Institute,Med-X Research Institute and School of Biomedical Engineering,Shanghai Jiao Tong University；State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；Institute of Materia Medica,Academy of Chinese and Western Integrative Medicine,Fudan University）.Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model[J].Acta Pharmaceutica Sinica B,2022,第8期 Yuan Gao，Jia-bo Wang（School of Traditional Chinese Medicine,Capital Medical University）.Commentary：Indirect action pattern：A remote and cross-organ pharmacological mechanism for drug innovation[J].Acta Pharmaceutica Sinica B,2022,第8期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第8期 Xiaoting Shan^1,2，Xiang Gong¹，Jie Li^1,3，Jingyuan Wen⁴，Yaping Li^1,2，Zhiwen Zhang^1,3,2（State Key Laboratory of Drug Research & Center of Pharmaceutics,Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmacy,University of Chinese Academy of Sciences；Yantai Key Laboratory of Nanomedicine & Advanced Preparations,Yantai Institute of Materia Medica；School of Pharmacy,University of Auckland）.Current approaches of nanomedicines in the market and various stage of clinical translation[J].Acta Pharmaceutica Sinica B,2022,第7期 Ziying Sun^1,2，Qianqian Liu³，Zhongyang Lv^1,2，Jiawei Li^1,2，Xingquan Xu^1,2，Heng Sun^1,2，Maochun Wang^1,2，Kuoyang Sun^1,2，Tianshu Shi^1,2，Zizheng Liu^1,2，Guihua Tan^1,2，Wenqiang Yan^1,2，Rui Wu^1,2，Yannick Xiaofan Yang^1,4，Shiro Ikegawa^1,5，Qing Jiang^1,2，Yang Sun³，Dongquan Shi^1,2（State Key Laboratory of Pharmaceutical Biotechnology,Department of Sports Medicine and Adult Reconstructive Surgery,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School；Laboratory for Bone and Joint Disease,Model Animal Research Center (MARC),Nanjing University；State Key Laboratory of Pharmaceutical Biotechnology,Department of Biotechnology and Pharmaceutical Sciences,School of Life Science,Nanjing University；Drum Tower of Clinical Medicine,Nanjing Medical University；Laboratory for Bone and Joint Diseases,RIKEN Center for Integrative Medical Science (IMS，RIKEN)）.Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling[J].Acta Pharmaceutica Sinica B,2022,第7期 Xu-Nian Wu¹，Qian Zhou¹，Ya-Dan Huang¹，Xi Xie²，Zhe Li¹，Yinuo Wu¹，Hai-Bin Luo^1,2（School of Pharmaceutical Sciences,Sun Yat-sen University；Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute,School of Pharmaceutical Sciences,Hainan University）.Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia[J].Acta Pharmaceutica Sinica B,2022,第7期 Fenglin Jiang，Chen Zhou，Yan Li，Haidong Deng，Ting Gong，Jingjing Chen，Tianjiao Chen，Jinling Yang，Ping Zhu（State Key Laboratory of Bioactive Substance and Function of Natural Medicines,NHC Key Laboratory of Biosynthesis of Natural Products,CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs,Institute of Materia Medica,Chinese Academy of Medical Sciences ＆ Peking Union Medical College）.Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM[J].Acta Pharmaceutica Sinica B,2022,第7期 Siyue Zhang^1,2,3,4，Fangyuan Xie^1,5，Kaichun Li⁶，He Zhang¹，You Yin⁷，Yuan Yu¹，Guangzhao Lu¹，Shihao Zhang⁸，Yan Wei³，Ke Xu³，Yan Wu⁹，Hong Jin¹⁰，Lan Xiao¹¹，Leilei Bao⁵，Can Xu¹²，Yulin Li^8,13，Ying Lu¹，Jie Gao^2,3（Department of Pharmacy,Naval Medical University；Changhai Clinical Research Unit,Shanghai Changhai Hospital,Naval Medical University；Institute of Translational Medicine,Shanghai University；Unit for Drug and Instrument Supervision and Inspection of Wuxi Joint Logistic Support Center；Department of Pharmacy,Shanghai Eastern Hepatobiliary Surgery Hospital,Naval Medical University；Department of Oncology,Shanghai Fourth People’s Hospital,School of Medicine,Tongji University；Department of Neurology,Changzheng Hospital,Naval Medical University；Key Laboratory for Ultrafine Materials of Ministry of Education,Engineering Research Center for Biomedical Materials of Ministry of Education,School of Materials Science and Engineering,East China University of Science and Technology；Department of Biomaterial,College of Life Sciences,Mudanjiang Medical University；Department of Laboratory Medicine,Hongqi Hospital,Mudanjiang Medical College；Centre for Biomedical Technologies,Queensland University of Technology；Department of Gastroenterology,Shanghai Changhai Hospital,Naval Medical University；Wenzhou Institute of Shanghai University）.Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization[J].Acta Pharmaceutica Sinica B,2022,第7期 Ashima Dhiman，Rupam Sharma，Rajesh K.Singh（Department of Pharmaceutical Chemistry,Shivalik College of Pharmacy,IKG Punjab Technical University）.Target-based anticancer indole derivatives and insight into structure-activity relationship：A mechanistic review update（2018—2021）[J].Acta Pharmaceutica Sinica B,2022,第7期 Ningna Weng¹，Siyuan Qin²，Jiayang Liu²，Xing Huang³，Jingwen Jiang²，Li Zhou²，Zhe Zhang²，Na Xie²，Kui Wang²，Ping Jin²，Maochao Luo²，Liyuan Peng²，Edouard C.Nice⁴，Ajay Goel⁵，Suxia Han⁶，Canhua Huang²，Qing Zhu¹（Department of Abdominal Oncology,West China Hospital of Sichuan University；State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,West China School of Basic Medical Sciences & Forensic Medicine,Sichuan University,Collaborative Innovation Center for Biotherapy；Department of Pancreatic Surgery,West China Hospital of Sichuan University；Department of Biochemistry and Molecular Biology,Monash University；Department of Molecular Diagnostics and Experimental Therapeutics,Beckman Research Institute of City of Hope,Biomedical Research Center；Department of Oncology,the First Affiliated Hospital,Xi'an Jiaotong University）.Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma[J].Acta Pharmaceutica Sinica B,2022,第7期 Tianming Ren^1,2，Runzhi Li^1,2，Liqiang Zhao²，J.Paul Fawcett¹，Dong Sun^1,2，Jingkai Gu^1,3,2（Research Center for Drug Metabolism,School of Life Sciences,Jilin University；Beijing Institute of Drug Metabolism；State Key Laboratory of Supramolecular Structure and Materials,Jilin University）.Biological fate and interaction with cytochromes P450 of the nanocarrier material, D-α-tocopheryl polyethylene glycol 1000 succinate[J].Acta Pharmaceutica Sinica B,2022,第7期 Sinan Ma¹，Jianai Ji¹，Yuanyuan Tong¹，Yuxuan Zhu¹，Junwei Dou¹，Xian Zhang¹，Shicheng Xu¹，Tianbao Zhu¹，Xiaoli Xu^1,2，Qidong You^1,2，Zhengyu Jiang^1,2（State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization,China Pharmaceutical University；Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University）.Non-small molecule PROTACs（NSM-PROTACs）：Protein degradation kaleidoscope[J].Acta Pharmaceutica Sinica B,2022,第7期 Yuhong Cao^1,2，Jiahao Fang¹，Yiwei Shi¹，Hui Wang¹，Xiaofei Chen¹，Yue Liu¹，Zhenyu Zhu¹，Yan Cao¹，Zhanying Hong¹，Yifeng Chai¹（School of Pharmacy,Second Military Medical University,Shanghai Key Laboratory for Pharmaceutical Metabolites Research；Zhejiang Institute for Food and Drug Control）.Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor[J].Acta Pharmaceutica Sinica B,2022,第7期 Jian He¹，Yu Huo¹，Zhikun Zhang¹，Yiqun Luo¹，Xiuli Liu¹，Qiaoying Chen¹，Pan Wu¹，Wei Shi²，Tao Wu³，Chao Tang¹，Huixue Wang¹，Lan Li¹，Xiyu Liu¹，Yong Huang¹，Yongxiang Zhao¹，Lu Gan¹，Bing Wang⁴，Liping Zhong¹（National Center for International Research of Biotargeting Theranostics,Guangxi Key Laboratory of Biotargeting Theranostics,Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy,Guangxi Talent Highland of Biotargeting Theranostics,Guangxi Medical University；The First Affiliated Hospital,Guangxi University of Chinese Medicine；The First People's Hospital of Changde City；Department of Spine Surgery,the Second Xiangya Hospital of Central South University）.Generation of αGal-enhanced bifunctional tumor vaccine[J].Acta Pharmaceutica Sinica B,2022,第7期 Bin Tu^1,2，Huiyuan Wang¹，Xinran An^1,3，Jingkun Qu^1,4，Qianqian Li^1,5，Yanrong Gao^1,2，Mingjie Shi¹，Hong Qiu¹，Yongzhuo Huang^1,2,6,7,8（State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；University of Chinese Academy of Sciences；University of Michigan College of Pharmacy；School of Chinese Materia Medica,Nanjing University of Chinese Medicine；Nanchang University College of Pharmacy；Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients；Taizhou University,School of Advanced Study,Institute of Natural Medicine and Health Product）.Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants[J].Acta Pharmaceutica Sinica B,2022,第7期 Qichao Yang¹，Xianbin Ma²，Yao Xiao¹，Tian Zhang²，Leilei Yang¹，Shaochen Yang¹，Mengyun Liang²，Shuo Wang¹，Zhizhong Wu¹，Zhigang Xu²，Zhijun Sun¹（The State Key Laboratory Breeding Base of Basic Science of Stomatology Hubei-MOST & Key Laboratory of Oral Biomedicine Ministry of Education,School & Hospital of Stomatology,Wuhan University；Key Laboratory of Luminescence Analysis and Molecular Sensing Southwest University,Ministry of Education，School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University）.Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity[J].Acta Pharmaceutica Sinica B,2022,第7期 Yi Zhu^1,2，Na Li¹，Mingyang Huang²，Xi Chen²，Yu A.An¹，Jianping Li³，Shangang Zhao¹，Jan-Bernd Funcke¹，Jianhong Cao⁴，Zhenyan He⁴，Qingzhang Zhu¹，Zhuzhen Zhang¹，Zhao V.Wang³，Lin Xu^5,6，Kevin W.Williams⁴，Chien Li⁷，Kevin Grove⁷，Philipp E.Scherer^1,8（Touchstone Diabetes Center,Department of Internal Medicine,the University of Texas Southwestern Medical Center at Dallas；Children's Nutrition Research Center,Department of Pediatrics,Baylor College of Medicine；Division of Cardiology,Department of Internal Medicine,the University of Texas Southwestern Medical Center at Dallas；Division of Hypothalamic Research,Department of Internal Medicine,the University of Texas Southwestern Medical Center at Dallas；Quantitative Biomedical Research Center,Department of Population and Data Sciences,the University of Texas Southwestern Medical Center at Dallas；Department of Pediatrics,the University of Texas Southwestern Medical Center at Dallas；Novo Nordisk Research Center；Department of Cell Biology,the University of Texas Southwestern Medical Center at Dallas）.Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention[J].Acta Pharmaceutica Sinica B,2022,第7期 Qing He，Hua Gao，Dejiang Tan，Heng Zhang，Jun-zhi Wang（National Institutes for Food and Drug Control,State Key Laboratory for Evaluation and Standardization of Innovative Vaccines and Biotechnology Products）.mRNA cancer vaccines：Advances, trends and challenges[J].Acta Pharmaceutica Sinica B,2022,第7期 Duxin Sun¹，Wei Gao¹，Hongxiang Hu¹，Simon Zhou²（Department of Pharmaceutical Sciences,College of Pharmacy,University of Michigan；Translational Development and Clinical Pharmacology,Bristol Meyer Squibb Company）.Why 90% of clinical drug development fails and how to improve it?[J].Acta Pharmaceutica Sinica B,2022,第7期 Shuai Yang^1,2，Lu Chen^1,2，Ying Tong^1,2，Wenqiang Yu^1,2（Laboratory of RNA Epigenetics,Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery,Huashan Hospital,Cancer Metastasis Institute,Shanghai Medical College,Fudan University；Shanghai Key Laboratory of Medical Epigenetics）.Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19[J].Acta Pharmaceutica Sinica B,2022,第7期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第7期 Haiming Xiao^1,2，Xiaohong Sun¹，Zeyuan Lin¹，Yan Yang¹，Meng Zhang^1,2，Zhanchi Xu³，Peiqing Liu^1,2，Zhongqiu Liu³，Heqing Huang^1,2（Laboratory of Pharmacology & Toxicology，School of Pharmaceutical Sciences，Sun Yat-sen University；National and Local United Engineering Lab of Druggability and New Drugs Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University；School of Pharmaceutical Sciences，Guangzhou University of Chinese Medicine）.Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism[J].Acta Pharmaceutica Sinica B,2022,第6期 Jiajia Xu¹，Wei Du¹，Yunhe Zhao²，Kahleong Lim³，Li Lu²，Chengwu Zhang^1,4，Lin Li^1,5（Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM)，Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM)，Nanjing Tech University (Nanjing Tech)；Department of Anatomy，Shanxi Medical University；Lee Kang Chian School of Medicine，Nanyang Technological University；School of Basic Medical Sciences，Shanxi Medical University；The Institute of Flexible Electronics (IFE，Future Technologies)，Xiamen University）.Mitochondria targeting drugs for neurodegenerative diseases——Design, mechanism and application[J].Acta Pharmaceutica Sinica B,2022,第6期 Jingya Zhao，Huabei Huang，Jinyan Zhao，Xiang Xiong，Sibo Zheng，Xiaoqing Wei，Shaobing Zhou（Key Laboratory of Advanced Technologies of Materials，Ministry of Education，School of Materials Science and Engineering，Southwest Jiaotong University）.A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第6期 Yamin Li^1,2，Zhongfeng Ye¹，Hanyi Yang¹，Qiaobing Xu¹（Department of Biomedical Engineering，Tufts University；Department of Pharmacology，State University of New York，Upstate Medical University）.Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins,and drugs[J].Acta Pharmaceutica Sinica B,2022,第6期 Xiliang Du¹，Chiara Di Malta^2,3，Zhiyuan Fang¹，Taiyu Shen¹，Xiaodi Niu⁴，Meng Chen¹，Bo Jin¹，Hao Yu¹，Lin Lei¹，Wenwen Gao¹，Yuxiang Song¹，Zhe Wang¹，Chuang Xu⁵，Zhijun Cao⁶，Guowen Liu¹，Xinwei Li¹（Key Laboratory of Zoonosis，Ministry of Education，College of Veterinary Medicine，Jilin University；Telethon Institute of Genetics and Medicine (TIGEM) Via Campi Flegrei 34；Medical Genetics Unit，Department of Medical and Translational Science，Federico Ⅱ University；College of Food Science and Engineering，Jilin University；College of Animal Science and Veterinary Medicine，Heilongjiang Bayi Agricultural University；State Key Laboratory of Animal Nutrition，Beijing Engineering Technology Research Center of Raw Milk Quality and Safety Control，College of Animal Science and Technology，China Agricultural University）.Nuciferine protects against high-fat diet-induced hepatic steatosis and insulin resistance via activating TFEB-mediated autophagy——lysosomal pathway[J].Acta Pharmaceutica Sinica B,2022,第6期 Yun Yang¹，Danrong Hu¹，Yi Lu²，Bingyang Chu¹，Xinlong He¹，Yu Chen¹，Yao Xiao¹，Chengli Yang¹，Kai Zhou¹，Liping Yuan¹，Zhiyong Qian¹（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University，Collaborative Innovation Center of Biotherapy；West China School of Pharmacy，Sichuan University）.Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy[J].Acta Pharmaceutica Sinica B,2022,第6期首页上一页 2 3 4 5 6 下一页尾页共有11页，转到页

期刊文章列表